VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CNSCohen & Steers, Inc.
$78.38$4.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksCNSFinancials

Cohen & Steers, Inc. (CNS) Financials

24Y historyFree accessUpdated daily

The firm maintains structural pricing power with gross margins consistently hovering near the 50% range, despite a notable $34.6 million stock-based compensation expense in 2025Q4.

CNS Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02
Sales/Revenue574.61M------------------------
Revenue Growth %-------------------------
Cost of Goods Sold0------------------------
COGS % of Revenue-------------------------
Gross Profit381.59M326.52M242.3M235.29M281.96M312.5M159.36M212.16M210.2M205.62M184.87M186.22M175.73M164.04M146.3M213.38M90.9M50.92M99.16M214.61M00070.34M55.77M
Gross Margin %66.41%57.51%46.83%48.05%49.15%53.53%36.98%51.64%53.69%53.68%52.28%56.39%55.98%54.68%52.99%89.94%49.09%41.22%53.36%84.14%---100%100%
Gross Profit Growth %-34.76%2.98%-16.55%-9.77%96.1%-24.89%0.93%2.23%11.22%-0.73%5.97%7.13%12.13%-31.44%134.74%78.51%-48.65%-53.79%----100%26.12%-
Operating Expenses197.92M148.78M69.42M70.81M66.03M52.13M64.3M52.03M63.16M50.87M49.35M58.67M53.79M57.7M49.86M126.38M38.12M33.36M40.28M115.14M-2.5M-53.88M1.28M58.47M-14.29M
OpEx % of Revenue-26.2%13.42%14.46%11.51%8.93%14.92%12.66%16.13%13.28%13.96%17.76%17.13%19.23%18.06%53.27%20.58%27%21.68%45.14%---83.12%-25.61%
Selling, General & Admin54.06M71.23M60.13M66.7M54.83M48.03M56.29M47.63M48.27M42.22M42.99M50.85M47.34M46.8M39.43M119.58M31.17M28.35M32.24M99.24M28.79M23.3M12.97M8.01M32.31M
SG&A % of Revenue-12.55%11.62%13.62%9.56%8.23%13.06%11.59%12.33%11.02%12.16%15.4%15.08%15.6%14.28%50.4%16.83%22.95%17.35%38.91%---11.38%57.94%
Research & Development0------------------------
R&D % of Revenue-------------------------
Other Operating Expenses0------------------------
Operating Income183.67M177.74M172.88M164.48M215.94M260.37M95.06M160.13M147.04M154.75M135.51M127.55M121.94M106.34M96.43M87M52.79M17.56M58.88M99.47M2.5M53.88M-1.28M11.87M70.06M
Operating Margin %31.96%31.3%33.41%33.59%37.64%44.6%22.06%38.98%37.55%40.4%38.32%38.62%38.84%35.45%34.93%36.67%28.5%14.21%31.68%39%---16.88%125.61%
Operating Income Growth %-2.81%5.11%-23.83%-17.07%173.91%-40.64%8.91%-4.98%14.19%6.24%4.6%14.67%10.28%10.84%64.82%200.55%-70.17%-40.81%3878.88%-95.36%4302.73%-110.8%-83.05%-
EBITDA194.44M188.76M184.05M169.62M221.6M276.44M111.33M175.16M160.88M166.63M139.76M133.76M126.56M114.96M101.99M92.06M57.32M21.78M62.91M106.46M8.9M60.16M5.8M12.87M72.68M
EBITDA Margin %33.84%33.24%35.57%34.64%38.63%47.35%25.84%42.64%41.09%43.5%39.52%40.5%40.32%38.32%36.94%38.8%30.95%17.63%33.85%41.74%---18.3%130.32%
EBITDA Growth %2.8%2.56%8.51%-23.46%-19.84%148.3%-36.44%8.88%-3.46%19.23%4.48%5.69%10.1%12.71%10.79%60.62%163.12%-65.37%-40.91%1095.8%-85.2%937.28%-54.95%-82.29%-
D&A (Non-Cash Add-back)10.77M11.02M11.17M5.14M5.67M16.06M16.27M15.03M13.84M11.89M4.25M6.21M4.62M8.62M5.56M5.06M4.53M4.22M4.03M6.99M6.4M6.28M7.08M1M2.63M
EBIT196.05M189.42M192.22M164.48M222.76M263.25M98.42M166.85M157.46M159.08M137.63M129.15M124M108.62M98.96M88.07M54.24M17.56M58.88M99.47M-4.99M46.7M-2.41M11.87M8.65M
Net Interest Income15.63M10.32M19.34M14.62M6.82M2.88M3.36M6.72M10.43M4.33M2.12M1.6M2.06M2.28M2.53M1.07M1.45M1.87M5.91M7.78M00000
Interest Income15.63M10.32M19.34M14.62M6.82M2.88M3.36M6.72M10.43M4.33M2.12M1.6M2.06M2.28M2.53M1.07M1.45M1.87M5.91M7.78M00000
Interest Expense0000000000000000000000000
Other Income/Expense0------------------------
Pretax Income208.88M204.63M209.54M180.25M196.9M281.94M93.39M187.55M143.78M160.4M143.4M112.74M122.01M104.36M104.3M86.86M65.49M4.15M45.88M109.48M2.5M53.88M-1.28M12.15M9.05M
Pretax Margin %36.35%36.04%40.5%36.81%34.32%48.29%21.67%45.65%36.72%41.88%40.55%34.14%38.87%34.79%37.78%36.61%35.37%3.36%24.69%42.92%---17.27%16.22%
Income Tax53.55M47.23M46.75M43.64M47.41M55.79M18.22M40.56M34.26M67.91M50.59M48.41M46.28M41.11M36.41M32.58M19.09M4.49M20.82M41.38M-837K22.88M-8.55M100K611K
Effective Tax Rate %25.64%23.08%22.31%24.21%24.08%19.79%19.51%21.63%23.83%42.34%35.28%42.94%37.93%39.39%34.91%37.51%29.15%108.09%45.38%37.79%-33.48%42.47%667%0.82%6.75%
Net Income155.81M153.22M151.26M129.05M171.04M211.4M76.58M134.62M113.9M91.94M92.94M64.55M75.51M68.12M66.12M54.31M46.4M-1.71M18.06M75.5M3.2M31.92M7.29M12.05M8.44M
Net Margin %27.12%26.98%29.23%26.36%29.81%36.21%17.77%32.77%29.09%24%26.28%19.55%24.05%22.71%23.95%22.89%25.05%-1.38%9.72%29.6%---17.13%15.13%
Net Income Growth %-0.78%1.29%17.22%-24.55%-19.09%176.03%-43.11%18.2%23.88%-1.07%43.97%-14.51%10.85%3.03%21.75%17.05%2813.27%-109.47%-76.08%2256.3%-89.96%337.99%-39.52%42.85%-
Net Income (Continuing)155.33M157.4M162.79M136.61M149.49M226.15M75.17M146.98M109.52M92.49M92.81M64.34M75.73M63.26M67.9M54.28M46.41M-336K25.06M68.1M3.2M31.92M7.29M12.05M8.44M
Discontinued Operations00000000000000000-10K-7M7.39M00000
Minority Interest103.62M71.89M63.19M111.42M89.39M89.14M50.66M53.41M114.19M47.8M853K11.33M607K207K53.19M4.8M000000000
EPS (Diluted)3.022.982.972.603.474.311.572.792.401.962.001.411.651.511.491.231.07-0.040.431.770.080.790.230.450.32
EPS Growth %-0.98%0.34%14.23%-25.07%-19.49%174.52%-43.73%16.25%22.45%-2%41.84%-14.55%9.27%1.34%21.14%14.95%2775%-109.3%-75.71%2112.5%-89.87%243.48%-48.89%40.63%-
EPS (Basic)-2.993.002.623.514.381.602.852.431.982.021.421.691.541.511.261.09-0.040.431.800.080.800.230.450.32
Diluted Shares Outstanding51.59M51.64M50.94M49.55M49.3M49.09M48.68M48.3M47.38M46.98M46.43M45.9M45.64M45.08M44.48M43.98M43.23M42.34M42.09M42.66M40.71M40.32M31.94M26.78M26.36M
Basic Shares Outstanding51.44M51.24M50.41M49.31M48.78M48.32M47.8M47.27M46.79M46.35M45.95M45.43M44.79M44.27M43.77M43.19M42.72M42.34M41.86M41.87M40.03M39.99M31.82M26.78M26.36M
Dividend Payout Ratio-82.84%78.79%87.13%62.76%69.8%159.94%120.86%157.05%106.93%76.21%105.62%111.56%116.99%147.02%127.27%220.7%-174.92%51.3%570.47%51.18%54.65%76.8%87%

Key Metrics

Growth RegimeExpanding
ProfitabilityStrong
Balance SheetFortress
Cash FlowRobust
Top Statement Risk

Interest rate sensitivity

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Growth Amid Market Volatility

As reported in recent financial statements, CNS achieved a 9.74% year-over-year revenue increase, suggesting that the firm's specialized active management model maintains resilience despite broader macroeconomic headwinds that typically pressure asset-based fee structures in the yield-sensitive real estate and preferred security sectors.

The revenue trajectory appears to be supported by the firm's ability to retain institutional capital, which likely provides a buffer against the cyclical nature of its underlying asset classes. Investors should monitor whether this growth is driven by market appreciation of AUM or genuine net organic inflows, as the latter is a more reliable indicator of long-term competitive durability.

Structural Margin Stability and Pricing

Based on the provided income statement data, the firm maintains a consistent gross margin profile, typically hovering near the 50% range, which suggests that the firm possesses sufficient pricing power to offset the costs associated with managing complex, niche investment vehicles.

The notable spike in gross margin to 85.3% in 2026Q1 warrants further investigation, as it may represent a non-recurring accounting adjustment rather than a permanent shift in the cost-to-revenue relationship. Sustained margins at these levels indicate that the firm's specialized research capabilities remain highly valued by clients, shielding it from the aggressive fee compression seen in commoditized passive products.

Stock-Based Compensation and Net Income

According to the quarterly income statement data, stock-based compensation reached a significant $34.6 million in 2025Q4, which appears to have temporarily depressed net income and highlights the importance of adjusting for non-cash expenses when evaluating the firm's true underlying profitability.

The volatility in quarterly net income, particularly when compared to the more stable operating income, suggests that non-operating items and compensation timing can obscure core performance. Analysts should focus on the consistency of operating margins to gauge the firm's ability to convert fee revenue into shareholder value without excessive dilution or compensation-related earnings distortion.

Disciplined Operating Expense Management

As evidenced by the historical income statement figures, the firm has demonstrated disciplined control over SG&A expenses, which have remained relatively contained even as revenue has scaled, indicating an efficient operating structure that leverages existing research and distribution infrastructure.

The firm's ability to keep SG&A expenses from ballooning suggests that management is successfully avoiding the common pitfall of over-investing in headcount during market upswings. This expense discipline appears to be a key driver of the firm's ability to maintain healthy operating margins, even during periods of market-driven revenue contraction.

CNS — Frequently Asked Questions

Quick answers to the most common questions about buying CNS stock.

Is Cohen & Steers, Inc. (CNS) profitable?

Cohen & Steers, Inc. (CNS) is profitable, generating $153.2M in net income for the fiscal year ending 2025 with a net profit margin of 27.0%.

What is Cohen & Steers, Inc.'s operating profit margin?

Cohen & Steers, Inc. (CNS) reported an operating income of $177.7M, resulting in an operating profit margin of 31.3%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Cohen & Steers, Inc.'s gross profit and gross margin?

Cohen & Steers, Inc. (CNS) generated $326.5M in gross profit for the year, representing a gross profit margin of 57.5%. This demonstrates the company's core pricing power and production efficiency.